1. Grobe W, Bieber T, Novak N. Pathophysiology of atopic dermatitis. J Dtsch Dermatol Ges. 2019;17:433–440.
2. Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, et al. Japanese guidelines for atopic dermatitis 2020. Allergol Int. 2020;69:356–369.
3. Egeberg A, Thyssen JP, Wu JJ, Pierce E, Terres JAR. Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral. Dermatol Ther. 2021;11:499–512.
4. Soniya M, Kumar GL, Kumar KA, Manisha B, Asit M, Sharad M, et al. Topical Corticosteroids Abuse: A Clinical Study of Cutaneous Adverse Effects. Indian J Dermatol. 2017;62:675.
8. Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 2007;115:246–270.
9. Park JW, Heo DS, Yoon IJ, Oh MS. An Analysis of the Study Tendency on Bee Venom - Focusing on Study of Bee Venom in Domestic Theses. J Orient Rehabil Med. 2006;16:31–52.
11. Guimarães D, Artur CP, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601:120571.
12. Xing L, Dawei C, Liping X, Rongqing Z. Oral colon-specific drug delivery for bee venom peptide: Development of a coated calcium alginate gel beadsentrapped liposome. J Control Release. 2003;93:293–300.
13. Silva TC, De Paula Moura S, Ramos HR, De Araujo PS, Bueno Da Costa MH. Design of a Modern Liposome and Bee Venom Formulation for the Traditional VIT-Venom Immunotherapy. J Liposome Res. 2008;18:353–368.
15. Kim JE, Kim JS, Cho DH, Park HJ. Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis. Int J Mol Sci. 2016;17:1234.
16. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol. 2002;20:55–72.
21. Bernard AC. Growing Numbers of Children Suffer from Atopic Dermatitis. Dermatol Nurs. 2006;18:292–303.
22. Spergel JM. Immunology and Treatment of Atopic Dermatitis: Division of Allergy and Immunology. Am J Clin Dermatol. 2008;9:233–241.
23. Li KS. Itch in atopic dermatitis: From pathogenesis to treatment. Allergy Asthma Respir Dis. 2014;2:8–15.
25. Han TY, Na CH, Lee JH, Kim HO, Park CO, Seo YJ, et al. Treatment of Atopic Dermatitis. Korean J Dermatol. 2018;56:581–593.
26. Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticosteroid induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol. 2001;7:73–77.
27. Rademaker M, Agnew K, Andrews M, Baker C, Foley P, Gebaue K, et al. Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative. Australas J Dermatol. 2020;61:9–22.
28. Schmitt J, Schwarz K, Baurecht H, Hotze M, Fölster-Holst R, Rodríguez E, et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol. 2016;137:130–136.
29. Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, Erkens AS, et al. Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration. J Allergy Clin Immunol. 2018;141:1668–1676.
31. Han SM, Lee KG, Yeo JH, Baek HJ. Determination of Major Constituents of Honeybee Venom from Korea. J Apiculture. 2009;24:175–178.
32. Lee KG, Cho HJ, Bae YS, Park KK, Choe JY, Chung IK, et al. Bee venom suppresses LPS-mediated NO/iNOS induction through inhibition of PKC-α expression. J Ethnopharmacol. 2009;123:15–21.
33. Cha HY, Ahn SH, Cheon JH, Park SY, Kim KB. Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in Dermatophagoides farinae-induced NC/Nga mice. J Ethnopharmacol. 2017;206:327–336.
34. Choi SW, Ahn JJ, Jung HC, Hong ES, Lee JH, Kim YH. A Case of Occupational Asthma Caused by Phthalic Anhydride. Korean J Asthma Allergy Clin Immunol. 2005;25:320–323.
35. Kim JH, Kim YM, Ahn KM. Effect of the indoor environment on atopic dermatitis in children. Allergy Asthma Respir Dis. 2020;8:175–183.